Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent

<div>Subgroup analysis for the primary endpoint in the matched population. DAPT, dual antiplatelet therapy; LV, left ventricle.</div>

Cardiology Research and Practice

fig2

Figure 2

Figure 2: Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent 

Figure 2 | Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent 